APPL1 and prostate carcinoma: Furthermore, Appl-1 distinguishes benign tissue through its basal cell distribution, which transitions to a cytoplasmic pattern in malignant cells, offering a pathophysiological basis for its precise detection of prostate cancer (Figure 1) [18,28].